Home | DAIC

New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure

News | Cardiovascular Clinical Studies

New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events

October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase ...

October 04, 2022

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.

News | AHA

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...

October 04, 2022

The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.

News | AHA

AHA Scientific Sessions 2022 Program, Late-breakers Announced

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...

October 04, 2022

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.

Gallery | TCT | By Melinda Taschetta-Millane and Christine Book

Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ...

October 03, 2022

Feature | TCT | By Christine Book

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review

The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...

October 03, 2022

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella for ...

October 03, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home

News | Heart Failure

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

October 03, 2022

The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice

News | Wearables

Mawi launches Mawi Heart Patch

October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring ...

October 03, 2022

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.

News | Congenital Heart

Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...

October 03, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

News | ECG

HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

September 29, 2022

Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder

News | Artificial Intelligence

AI-guided Screening Uses ECG Data to Detect a Hidden Risk Factor for Stroke

September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ ...

September 29, 2022

Higher blood levels of collagen-derived molecule predict worse outcomes

News | Heart Failure

Penn Study Identifies New Prognostic Biomarker for Heart Failure

September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...

September 29, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)

News | Stents Bioresorbable

BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...

September 28, 2022

Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst

News | Heart Failure

Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital

September 28, 2022 — A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are ...

September 28, 2022

Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient. Credit: Draper

News | Pediatric Cardiology

Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive

September 28, 2022 — Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...

September 28, 2022